US Patent Issued to Nxera Pharma UK on Jan. 20 for "5-amino-8-(4-pyridyl)-[1,2,4triazolo[4,3-cpyrimidin-3-one compounds for use against cancer" (British Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,815, issued on Jan. 20, was assigned to Nxera Pharma UK Ltd. (Cambridge, Great Britain).

"5-amino-8-(4-pyridyl)-[1,2,4triazolo[4,3-cpyrimidin-3-one compounds for use against cancer" was invented by Giles Albert Brown (Cambridge, Great Britain), Miles Stuart Congreve (Cambridge, Great Britain), Christine Mary Richardson (Saffron Walden, Great Britain), Rebecca Paul (St. Albans, Great Britain), Stephen Philippe Andrews (Royston, Great Britain), Jonathan Stephen Mason (Cambridge, Great Britain), Francesca Deflorian (Cambridge, Great Britain) and Nigel Alan Swain (Cambridge, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein a...